IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

20 filings reported holding 46333XAH1 - IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q2 2021.
IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 has 18 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $176,649,934 of principal .
Largest 10 bondholders include CITADEL ADVISORS LLC ($68,788,000 of principal), CAMDEN ASSET MANAGEMENT L P /CA ($37,725,000 of principal), LAZARD ASSET MANAGEMENT LLC ($16,318,000 of principal), CNH PARTNERS LLC ($13,500,000 of principal), CALAMOS ADVISORS LLC ($9,500,000 of principal), PUTNAM INVESTMENTS LLC ($7,564,000 of principal), Polar Asset Management Partners Inc. ($7,000,000 of principal), Linden Advisors LP ($6,998,000 of principal), SHENKMAN CAPITAL MANAGEMENT INC ($4,839,000 of principal), and DEUTSCHE BANK AG\ ($1,029,000 of principal).
This table shows the top 18 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.